Our Science

Publications 2018


Our scientific publications in high-quality journals reflect the quality of the innovative research in Entasis’ laboratories.

Damião Gouveia, A.C., Unemo, M. and Jensen, J.S.
In vitro activity of zoliflodacin (ETX0914) against macrolide-resistant fluoroquinolone-resistant and antimicrobial-susceptible Mycoplasma genitalium strains
J Antimicrobial Chemotherapy doi:10.1093/jac/dky022 (2018)

S. McLeod, A. Shapiro, S. Moussa, M. Johnstone, R. McLaughlin, B. de Jonge and A. Miller
Frequency and Mechanism of Spontaneous Resistance to Sulbactam Combined with the Novel β-Lactamase Inhibitor ETX2514 in Clinical Isolates of Acinetobacter baumannii
Antimicrob. Agents Chemother. February 2018 vol. 62 no. 2 e01576-17


“Our scientific approach and expertise, coupled with Entasis’ strong pipeline of programs, really make us stand out in the field of antibacterial drug discovery and development.”

— Satenig Guler, Senior Scientist